Trials / Sponsors / Wayshine Biopharm, Inc.
Wayshine Biopharm, Inc.
Industry · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC Non Small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2025-10-17 |
| Recruiting | A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2025-08-18 |
| Recruiting | A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung C EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-09-04 |